Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2020
has subject area
- 1103 Clinical Sciences (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Dermatology & Venereal Diseases (Science Metrix)
- Dose-Response Relationship, Drug (MeSH)
- Drug Administration Schedule (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Humans (MeSH)
- Injections, Subcutaneous (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Psoriasis (MeSH)
- Retrospective Studies (MeSH)
- Treatment Outcome (MeSH)